Arch Dermatol News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Arch Dermatol. Real-time updates on events, politics, business and more.

Study: Third of Individuals With Actinic Keratosis Unaware of Its Cause

May 28, 2024

Although sun-protective measures have been increasing, the incidence of skin cancer has also increased, suggesting better targeted interventions and patient education are needed.

Volker Koscielny Complejo Asistencial Universitario National Health Interview International Journal Of Molecular Science Archives Of Dermatological Research International Journal

Source: pharmacytimes.com

QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation

February 11, 2022

QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation - read this article along with other careers information, tips and advice on BioSpace

United States Jaclyn Jaffe Claude Maraoui Tony Plohoros Eli Lilly Company Contacts

Source: biospace.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Arch Dermatol News Today

Study: Third of Individuals With Actinic Keratosis Unaware of Its Cause

QBREXZA&#xAE; (Rapifort&#xAE; Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation

Explore More Categories

QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation